机构：[1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University.Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China
第一作者机构：[1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University.Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of NuclearMedicine, The Affiliated Hospital of Southwest Medical University.Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. Institute of NuclearMedicine, SouthwestMedical University, Luzhou, Sichuan, China[*1]Department of Nuclear Medicine, The Affiliated Hospital of SouthwestMedical University, No. 25 TaiPing St, Jiangyang District, Luzhou, Sichuan 646000, China.
推荐引用方式(GB/T 7714)：
Qu Gengcuo,Hua Qingchu,Li Hongmei,et al.177 Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer[J].Clinical Nuclear Medicine.2024,49(2):152-153.doi:10.1097/RLU.0000000000005010.
APA：
Qu Gengcuo,Hua Qingchu,Li Hongmei,Zhang Yu&Chen Yue.(2024).177 Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer.Clinical Nuclear Medicine,49,(2)
MLA：
Qu Gengcuo,et al."177 Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer".Clinical Nuclear Medicine 49..2(2024):152-153
